EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1 :: ALK Fusion

Havva Gokce Terzioglu iD, Phillip McMullen, Güliz A Barkan iD

Diagnostic Cytopathology · 2026-09 · 54 (9)

DOI: 10.1002/dc.70140 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Diagnostic Cytopathology, online erschienen am 22.05.2026. Verfasst von Havva Gokce Terzioglu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, Illinois, USA. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Lung Neoplasms, Sarcoma, Sequestosome-1 Protein. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare and aggressive variant of inflammatory myofibroblastic tumor (IMT) characterized by epithelioid morphology, atypical features, ALK rearrangements, and early metastatic potential. Primary pulmonary EIMS is exceptionally uncommon, and diagnosis on cytologic specimens can be challenging. A 58‐year‐old woman presented with cough and shortness of breath and was found to have a right lung mass. Transbronchial needle aspiration revealed scattered spindle cells in a lymphoplasmacytic background on the smears. Cell block sections demonstrated mainly spindle to few epithelioid cells with focal necrosis. Immunohistochemistry showed diffuse ALK positivity with focal SMA and desmin expression. The lesion was diagnosed as a spindle cell neoplasm concerning for an IMT with possible malignant transformation. Subsequent lobectomy revealed epithelioid morphology, marked atypia, increased mitotic activity, and extensive necrosis, establishing the diagnosis of EIMS. Molecular testing identified an SQSTM1::ALK fusion and a TERT promoter mutation. The patient developed metastatic disease and showed a limited response to ALK inhibitor therapy. This case highlights the diagnostic challenges of EIMS on cytology and underscores the importance of integrating cytomorphology, immunohistochemistry, and molecular testing for accurate diagnosis and management. It also expands the molecular spectrum of EIMS by demonstrating a rare SQSTM1::ALK fusion in a primary pulmonary tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anaplastic Lymphoma KinaseLung NeoplasmsSarcomaSequestosome-1 ProteinOncogene Proteins, FusionHumansFemaleMiddle AgedEpithelioid Cells

Stichwörter der Autor:innen

ALKSQSTM1epithelioid inflammatory myofibroblastic sarcoma

Substanzen

Anaplastic Lymphoma KinaseALK protein, humanSequestosome-1 ProteinOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Loyola University Medical Center, Maywood, Illinois, USA.

ORCID-Profile: Havva Gokce Terzioglu, Güliz A Barkan

Zitieren

APA

Terzioglu, H. G., McMullen, P., & Barkan, G. A. (2026). Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1 :: ALK Fusion. Diagnostic Cytopathology, 54(9). https://doi.org/10.1002/dc.70140

Vancouver

Terzioglu HG, McMullen P, Barkan GA. Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1 :: ALK Fusion. Diagnostic Cytopathology. 2026;54(9). doi:10.1002/dc.70140

BibTeX
@article{Terzioglu2026,
  author = {Terzioglu, Havva Gokce and McMullen, Phillip and Barkan, Güliz A},
  title = {Primary Pulmonary Epithelioid Inflammatory Myofibroblastic Sarcoma With SQSTM1 :: ALK Fusion},
  journal = {Diagnostic Cytopathology},
  year = {2026},
  volume = {54},
  number = {9},
  doi = {10.1002/dc.70140}
}
Kostenlos starten →